ΤSOTINIS ANDREW

Professor, Section of Pharmaceutical Chemistry

FULL CV

 

Studies

  • Degree: BS major in Chemistry, UNCC, North Carolina, U.S.A.
  • PhD in Synthetic Organic Chemistry, UCL, London, U.K.

Teaching

  • Undergraduate courses/labs: Organic Chemistry (I), Pharmaceutical Chemistry (I) / Drug Synthesis Practicals
  • Graduate courses: Application of the Retrosynthetic Methodology in the Preparation of Bioactive Compounds 

Research topics

  • Development of new synthetic methods. Design and synthesis of organic molecules with pharmacological activity [antineoplastic, antiviral, antibacterial, trypanocidal and Central Nervous System (CNS)].
  • Structural modification of bioactive natural products (e.g. melatonin) and their derivatives aiming at the improvement of their potency.

Distinctions

  • 1985-1986 Franz Sondheimer Bursary and Schilizzi Foundation Award  
  • 1986-1987 Franz Sondheimer Bursary
  • 1988           Permanent member, Convocation of the University of London
  • 1994           NHRF/Royal Society Award
  • 1995           NHRF/Royal Society Award

Recent publications (2017-2019)

  • Angeliki-Sofia Foscolos, Ioannis Papanastasiou, Andrew Tsotinis, Nicolas Kolocouris, George B. Foscolos, Anthony Vocat, Stewart T. Cole Synthesis of Adamantane Aminoethers with Antitubercular Potential” Medicinal Chemistry, 2017, 13, 670-681.
  • Stella Manta, Niki Tzioumaki, Nikolaos Kollatos, Pelagia Andrea, Marili Margaritouli, Aggeliki Panagiotopoulou, Ioannis Papanastasiou, Christos Mitsos, Andrew Tsotinis, Dominique Schols, Dimitri Komiotis “Polyfunctionalized Pyrrole Derivatives: Easy Three-component Microwave-assisted Synthesis, Cytostatic and Antiviral Evaluation” Current Microwave Chemistry, 2018, 5, 23-31.
  • Grigoris Zoidis, Andrew Tsotinis, Alexandra Tsatsaroni, Martin C Taylor, John M Kelly, Antonia Efstathiou, Despina Smirlis, George Fytas “Lipophilic conformationally constrained spiro carbocyclic 2, 6‐diketopiperazine‐1‐acetohydroxamic acid analogues as trypanocidal and leishmanicidal agents: An extended SAR study” Chemical Biology & Drug Design, 2018, 91, 408-421.
  • Marilena Vlachou, Konstantina Tragou, Angeliki Siamidi, Stefanos Kikionis, Angelos-Leontios Chatzianagnostou, Anastasis Mitsopoulos, Efstathia Ioannou, Vassilios Roussis, Andrew Tsotinis “Modified in vitro release of the chronobiotic hormone melatonin from matrix tablets based on the marine sulfated polysaccharide ulvan” Journal of Drug Delivery Science and Technology, 2018, 44, 41-48. 
  • Marilena Vlachou, Stefanos Kikionis, Angeliki Siamidi, Konstantina Tragou, Stefania Kapoti, Efstathia Ioannou, Vassilios Roussis, Andrew Tsotinis “Fabrication and characterization of electrospun nanofibers for the modified release of the chronobiotic hormone melatonin”Current Drug Delivery, 2019, 16, 79-85.
  • Andrew Tsotinis, Rodanthi Kompogennitaki, Ioannis Papanastasiou, Peter J Garratt, Alina Bocianowska, David Sugden “Fluorine substituted methoxyphenylalkyl amides as potent melatonin receptor agonists” MedChemComm, 2019, 10, 460-464.
  • Marilena Vlachou, Stefanos Kikionis, Angeliki Siamidi, Konstantina Tragou, Efstathia Ioannou, Vassilios Roussis, Andrew Tsotinis “Modified in vitro release of melatonin loaded in nanofibrous electrospun mats incorporated into monolayered and three-layered tablets” Journal of Pharmaceutical Sciences, 2019, 108, 970-976.
  • George Fytas, Grigoris Zoidis, Martin C Taylor, John M Kelly, Alexandra Tsatsaroni, Andrew Tsotinis “Novel 2,6-diketopiperazine-derived acetohydroxamic acids as promising anti-Trypanosoma brucei agents” Future medicinal chemistry, 2019, 11, 1259-1266.
  • Angeliki‐Sofia Foscolos, Ioannis Papanastasiou, Andrew Tsotinis, Martin C Taylor, John M Kelly “Synthesis and Evaluation of Nifurtimox–Adamantane Adducts with Trypanocidal Activity” ChemMedChem, 2019, 14, 1227-1231.
  • Markos-Orestis Georgiadis, Violeta Kourbeli, Vaya Ioannidou, Evangelos Karakitsios, Ioannis Papanastasiou, Andrew Tsotinis, Dimitri Komiotis, Anthony Vocat, Stewart T Cole, Martin C Taylor, John M Kelly “Synthesis of diphenoxyadamantane alkylamines with pharmacological interest” Bioorganic & Medicinal Chemistry Letters, 2019, 29, 1278-1281.
  • Andria Papageorgiou, Angeliki-Sofia Foscolos, Ioannis P Papanastasiou, Marilena Vlachou, Angeliki Siamidi, Anthony Vocat, Stewart T Cole, Tahsin F Kellici, Thomas Mavromoustakos, Andrew Tsotinis “Synthesis, biology, computational studies and in vitro controlled release of new isoniazid-based adamantane derivatives” Future medicinal chemistry, 2019, 65, in press.
  • Marilena Vlachou, Stefanos Kikionis, Angeliki Siamidi, Sotiria Kyriakou, Andrew Tsotinis, Efstathia Ioannou, Vassilios Roussis “Development and Characterization of Eudragit®-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide” Pharmaceutics, 2019, 480.

Contact 

Professor Andrew Tsotinis
University of Athens
Faculty of Pharmacy
Department of Pharmaceutical Chemistry
Panepistimioupoli-Zografou
157 71 Athens
GREECE

Tel.: +30 210 7274812
Fax.: +30 210 7274747

e-mail: tsotinis[at]pharm.uoa[dot]gr